Konopka, James B
- Stony Brook University · Microbiology & Immunology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #13,406
- R01 Holder
- Long-Funded
- Mentor
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Microbiology & Immunology
NIH Funding · FY2023
Linked Award Amount
$799.2K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#13,406
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Konopka, James B as a PI. Multi-PI records show the full award amount for context.
- 5R01AI047837-21R01Contact PIPlasma membrane promotes stress resistance and virulence of Candida albicansStony Brook University · Microbiology & Immunology (NIH department code)$528.8Kaward amount
- 5T32AI007539-25T32Contact PIMolecular and Cell Biology of Infectious DiseasesStony Brook University · Microbiology & Immunology (NIH department code)$270.4Kaward amount
Award organization
Organizations that administered FY2023 awards listing Konopka, James B as a PI.
FY2023 award administered by Stony Brook University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardStony Brook University
- 2007$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2010$2M Cumulative Funding
- 2012R01 Grant Holder
- 2015Entered Top 50% NationallyRanked #7843
- 2016$5M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #4726
- 2021$10M Cumulative Funding